new glp 1 medication GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity Professor Receives Grant to Study

Rehabilitative treatment in peripheral artery disease: protocol application and follow-up

OSDI = Ocular Surface Disease Index

Patienten, die nach einem Herzinfarkt mit L-Carnitin behandelt wurden, entwickelten wesentlich seltener Herzrhythmusstrungen und eine Angina pectoris und hatten hhere berlebensraten als unbehandelte Patienten

Medicines regulator approves up to 7.2 mg dose of semaglutide (Wegovy) for patients with obesity only

These findings explain why nad infusion with glutathione treatments work by fixing core metabolic problems instead of just treating symptoms

Limitations of the present study include the relatively short duration of the observation